Aberrant expression of KITLG by autocrine/paracrine stimulation mechanisms has been discovered in various cancers, such as colorectal cancer [31], non-small cell lung cancer [32], glioblastoma [33], and thymoma [34]. Here, KITLG is linked to non-small cell lung carcinoma.